Pilus vaccines - PubMed (original) (raw)
Review
Pilus vaccines
E C Tramont et al. Vaccine. 1985 Mar.
Abstract
Bacterial pili (fimbriae) are protein appendages which extend from the cell surface and serve to adhere the microorganism to body surfaces. These appendages have been isolated, purified and characterized as vaccine candidates. These vaccines stimulate an immune response which serves at least with regards to Neisseria gonorrhoeae to block the adherence of the microorganism to epithelial cells. Thus far, these vaccines have proven effective in some animal studies and in a limited number of human challenge studies. The problems that remain are: lack of broad cross reactivity of the vaccines thus far developed poor immunogenicity of the important binding ligands both in terms of quality and quantity of antibody produced and inadequate stimulation of antibody response at the local site of infection.
Similar articles
- A pilus peptide vaccine for the prevention of gonorrhea.
Schoolnik GK, Tai JY, Gotschlich EC. Schoolnik GK, et al. Prog Allergy. 1983;33:314-31. Prog Allergy. 1983. PMID: 6187017 Review. No abstract available. - Vaccinating with bacterial pili.
Marx JL. Marx JL. Science. 1980 Sep 5;209(4461):1103-6. doi: 10.1126/science.6105710. Science. 1980. PMID: 6105710 No abstract available. - Genital antibody response to a parenteral gonococcal pilus vaccine.
McChesney D, Tramont EC, Boslego JW, Ciak J, Sadoff J, Brinton CC. McChesney D, et al. Infect Immun. 1982 Jun;36(3):1006-12. doi: 10.1128/iai.36.3.1006-1012.1982. Infect Immun. 1982. PMID: 6124502 Free PMC article. - Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
Sparling PF, Cannon JG, So M. Sparling PF, et al. J Infect Dis. 1986 Feb;153(2):196-201. doi: 10.1093/infdis/153.2.196. J Infect Dis. 1986. PMID: 2418125 Review. No abstract available. - Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin.
Johnson SC, Chung RC, Deal CD, Boslego JW, Sadoff JC, Wood SW, Brinton CC Jr, Tramont EC. Johnson SC, et al. J Infect Dis. 1991 Jan;163(1):128-34. doi: 10.1093/infdis/163.1.128. J Infect Dis. 1991. PMID: 1701817 Clinical Trial.
Cited by
- Regulation of pap pilin phase variation by a mechanism involving differential dam methylation states.
Blyn LB, Braaten BA, Low DA. Blyn LB, et al. EMBO J. 1990 Dec;9(12):4045-54. doi: 10.1002/j.1460-2075.1990.tb07626.x. EMBO J. 1990. PMID: 2147413 Free PMC article. - Force-dependent polymorphism in type IV pili reveals hidden epitopes.
Biais N, Higashi DL, Brujic J, So M, Sheetz MP. Biais N, et al. Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11358-63. doi: 10.1073/pnas.0911328107. Epub 2010 Jun 3. Proc Natl Acad Sci U S A. 2010. PMID: 20534431 Free PMC article. - Experimental Urethral Infection with Neisseria gonorrhoeae.
Waltmann A, Duncan JA, Pier GB, Cywes-Bentley C, Cohen MS, Hobbs MM. Waltmann A, et al. Curr Top Microbiol Immunol. 2024;445:109-125. doi: 10.1007/82_2021_250. Curr Top Microbiol Immunol. 2024. PMID: 35246736 Free PMC article. Review. - Vaccines for gonorrhea: can we rise to the challenge?
Zhu W, Chen CJ, Thomas CE, Anderson JE, Jerse AE, Sparling PF. Zhu W, et al. Front Microbiol. 2011 Jun 3;2:124. doi: 10.3389/fmicb.2011.00124. eCollection 2011. Front Microbiol. 2011. PMID: 21687431 Free PMC article. - Vertebrate and Invertebrate Animal and New In Vitro Models for Studying Neisseria Biology.
Girgis MM, Christodoulides M. Girgis MM, et al. Pathogens. 2023 May 30;12(6):782. doi: 10.3390/pathogens12060782. Pathogens. 2023. PMID: 37375472 Free PMC article. Review.